Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 31;11(6):508.
doi: 10.3390/life11060508.

Intracranial Venous Hypertension and Venous Sinus Stenting in the Modern Management of Idiopathic Intracranial Hypertension

Affiliations

Intracranial Venous Hypertension and Venous Sinus Stenting in the Modern Management of Idiopathic Intracranial Hypertension

Robert K Townsend et al. Life (Basel). .

Abstract

Idiopathic intracranial hypertension (IIH) is a debilitating condition that has traditionally been difficult to treat. In recent years, there has been increasing focus on the role of intracranial venous hypertension in the pathophysiology of IIH. Based on increased understanding of this pathophysiology, venous sinus stenting (VSS) has emerged as a safe and reliable treatment for a certain population of patients with IIH. Stratifying patients with IIH based on the status of their venous outflow can provide insight into which patients may enjoy reduction in their symptoms after VSS and provides information regarding why some patients may have symptom recurrence. The traditional view of IIH as a disease due to obesity in young women has been cast into doubt as the understanding of the role of intracranial venous hypertension has improved.

Keywords: idiopathic intracranial hypertension; pseudotumor cerebri; venous manometry; venous sinus stenting.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Fargen K.M. Idiopathic intracranial hypertension is not idiopathic: Proposal for a new nomenclature and patient classification. J. Neurointerv. Surg. 2020;12:110–114. doi: 10.1136/neurintsurg-2019-015498. - DOI - PubMed
    1. Fargen K.M. A unifying theory explaining venous sinus stenosis and recurrent stenosis following venous sinus stenting in patients with idiopathic intracranial hypertension. J. Neurointerv. Surg. 2021 doi: 10.1136/neurintsurg-2020-017208. - DOI - PubMed
    1. Higgins J.N.P., Owler B.K., Cousins C., Pickard J.D. Venous sinus stenting for refractory benign hypertension. Lancet. 2002;359:228–230. doi: 10.1016/S0140-6736(02)07440-8. - DOI - PubMed
    1. Fargen K.M., Liu K., Garner R.M., Greeneway G.P., Wolfe S.Q., Crowley R.W. Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting. J. Neurointerv. Surg. 2018;10:1203–1208. doi: 10.1136/neurintsurg-2018-014042. - DOI - PubMed
    1. Pollay M. The function and structure of the cerebrospinal fluid outflow system. Cerebrospinal Fluid Res. 2010;7:9. doi: 10.1186/1743-8454-7-9. - DOI - PMC - PubMed

LinkOut - more resources